Arch Therapeutics Inc. to Present at the LD MICRO Invitational 2014 on June 4th
May 28, 2014 09:00 ET
|
Arch Therapeutics, Inc.
WELLESLEY, MA--(Marketwired - May 28, 2014) - Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), a life sciences company and developer of the AC5 Surgical Hemostatic Device™, a...
Arch Therapeutics Inc. to Present at the Third Annual Marcum MicroCap Conference
May 27, 2014 09:00 ET
|
Arch Therapeutics, Inc.
WELLESLEY, MA--(Marketwired - May 27, 2014) - Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), a life sciences company and developer of the AC5 Surgical Hemostatic Device™, a...
Cabot Microelectronics Corporation to Participate in D.A. Davidson & Co. 6th Annual Technology Investor Forum
May 21, 2014 11:00 ET
|
CMC Materials
Aurora, IL, May 21, 2014 (GLOBE NEWSWIRE) -- Cabot Microelectronics Corporation (NASDAQ:
CCMP), the world's leading supplier of chemical mechanical
planarization (CMP) polishing slurries and a growing...
Arch Therapeutics Appoints Chirag Shah, PhD as Vice President of R&D Engineering and Quality Systems and Peter LaCrosse as Chief of Staff
April 01, 2014 08:00 ET
|
Arch Therapeutics, Inc.
WELLESLEY, MA--(Marketwired - Apr 1, 2014) - Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), a life sciences company and developer of the AC5 Surgical Hemostatic Device™, a...
Arch Therapeutics Co-Founder Rutledge Ellis-Behnke, PhD Presents at Two Scientific Meetings in March
March 26, 2014 09:00 ET
|
Arch Therapeutics, Inc.
WELLESLEY, MA--(Marketwired - Mar 26, 2014) - Rutledge Ellis-Behnke, PhD, co-founder and inventing scientist at Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or "the Company"), a life sciences...
Arch Therapeutics to Present at The Wall Street Analyst Forum Institutional Investor Conference
February 26, 2014 09:00 ET
|
Arch Therapeutics, Inc.
WELLESLEY, MA--(Marketwired - Feb 26, 2014) - Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), a life sciences company and developer of the AC5 Surgical Hemostatic Device™, a...
Arch Therapeutics Secures $2.85 Million Private Placement
February 10, 2014 09:00 ET
|
Arch Therapeutics, Inc.
WELLESLEY, MA--(Marketwired - Feb 10, 2014) - Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), a life sciences company and developer of the AC5 Surgical Hemostatic Device™, a...
Arch Therapeutics Announces $2.85 Million Private Placement
January 31, 2014 06:00 ET
|
Arch Therapeutics, Inc.
WELLESLEY, MA--(Marketwired - Jan 31, 2014) - Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), a life sciences company and developer of the AC5 Surgical Hemostatic Device™, a...
Arch Therapeutics Presents 2014 Milestones During Live Webcast
January 22, 2014 11:00 ET
|
Arch Therapeutics, Inc.
WELLESLEY, MA--(Marketwired - Jan 22, 2014) - Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), a life sciences company and developer of the AC5 Surgical Hemostatic Device™, a...
Arch Therapeutics to Present Status Update and Milestone Overview at Noble Financial Capital Markets' Tenth Annual Equity Conference
January 14, 2014 09:00 ET
|
Arch Therapeutics, Inc.
WELLESLEY, MA--(Marketwired - Jan 14, 2014) - Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), a life sciences company and developer of the AC5 Surgical Hemostatic Device™, a...